Webinar: RADx Tech Accessible Tests Program Best Practices - CIMIT MAIN

Responsive Image
The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Programs and Offerings

News and Events

null Webinar: RADx Tech Accessible Tests Program Best Practices

Webinar: RADx Tech Accessible Tests Program - Best Practices

Since the Spring of 2022, RADx Tech has been working to make COVID-19 home tests more accessible (our previous webinar addressed these efforts). During this work, the team has also captured what we've learned (from knowledgeable evaluators, designers, SMEs and vendors in the field) in a best practices document. While a comprehensive document is anticipated this Spring, an early edition of these best practices, with insights so far, was published in December, with support from NIH, on the US Access Board website site. While it is based on COVID test development, we hope it will have future applications across the field of home test design.

Speakers:  
Brian Walsh 
RADx Tech Accessibility Program Manager, Deployment Core Team Lead

Clair O’Donovan, PhD
RADx Tech Team Leader

John Blackwood
RADx Team Leader

When: 
February 28th, 2023
2PM ET

Watch the recording >

Download the slides >

If you need assistance registering for this webinar please call 617-643-3800 or email cimitcommunications@partners.org.

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, CIMIT has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.